Evaluation of dilute hydrogen peroxide technology for continuous room decontamination of multidrug-resistant organisms.
William A Rutala, Hajime Kanamori, Maria F Gergen, Emily E Sickbert-Bennett, Deverick J Anderson, Daniel J Sexton, David J Weber, CDC Prevention Epicenters Program
Author Information
- William A Rutala: Division of Infectious Diseases, University of North Carolina School of Medicine, Chapel Hill, North Carolina, United States.
- Hajime Kanamori: Division of Infectious Diseases, University of North Carolina School of Medicine, Chapel Hill, North Carolina, United States.
- Maria F Gergen: Lumagenics, Cary, North Carolina, United States.
- Emily E Sickbert-Bennett: Division of Infectious Diseases, University of North Carolina School of Medicine, Chapel Hill, North Carolina, United States.
- Deverick J Anderson: Division of Infectious Diseases, Duke Center for Antimicrobial Stewardship and Infection Prevention, Duke University Medical Center, Durham, North Carolina, United States.
- Daniel J Sexton: Division of Infectious Diseases, Duke Center for Antimicrobial Stewardship and Infection Prevention, Duke University Medical Center, Durham, North Carolina, United States.
- David J Weber: Division of Infectious Diseases, University of North Carolina School of Medicine, Chapel Hill, North Carolina, United States.
No abstract text available.
- U54 CK000483/NCEZID CDC HHS
Aerosols
Cross Infection
Decontamination
Drug Resistance, Multiple, Bacterial
Equipment Contamination
Hospitals
Humans
Hydrogen Peroxide
Patients' Rooms
Aerosols
Hydrogen Peroxide
